Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Kamada Ltd (KMDA)

Kamada Ltd (KMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 278,695
  • Shares Outstanding, K 44,520
  • Annual Sales, $ 133,250 K
  • Annual Income, $ 17,140 K
  • 60-Month Beta 1.07
  • Price/Sales 2.17
  • Price/Cash Flow 13.11
  • Price/Book 1.63
Trade KMDA with:

Options Overview

Details
  • Implied Volatility 81.03%
  • Historical Volatility 64.11%
  • IV Percentile 1%
  • IV Rank 8.34%
  • IV High 357.85% on 11/09/20
  • IV Low 55.86% on 02/24/21
  • Put/Call Vol Ratio 1.87
  • Today's Volume 66
  • Volume Avg (30-Day) 401
  • Put/Call OI Ratio 1.56
  • Today's Open Interest 3,313
  • Open Int (30-Day) 2,430

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.07
  • Low Estimate 0.02
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -58.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.98 +2.68%
on 02/26/21
8.16 -24.75%
on 02/09/21
-0.59 (-8.77%)
since 01/26/21
3-Month
5.98 +2.68%
on 02/26/21
8.16 -24.75%
on 02/09/21
-0.48 (-7.25%)
since 11/25/20
52-Week
4.40 +39.55%
on 03/16/20
13.33 -53.94%
on 08/24/20
unch (unch)
since 02/26/20

Most Recent Stories

More News
Kamada Files Annual Report for the Year Ended December 31, 2020

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020, with the U.S....

KMDA : 6.14 (-1.92%)
Kamada (KMDA) Misses Q4 Earnings and Revenue Estimates

Kamada (KMDA) delivered earnings and revenue surprises of -42.86% and -4.89%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 6.14 (-1.92%)
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced financial results for the three and 12 months ended December 31, 2020.

KMDA : 6.14 (-1.92%)
Kamada Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Kamada Ltd. (NASDAQ:KMDA) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 10, 2021 at 8:00 AM...

KMDA : 6.14 (-1.92%)
Earnings Preview: Kamada (KMDA) Q4 Earnings Expected to Decline

Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KMDA : 6.14 (-1.92%)
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021

Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2020, prior...

KMDA : 6.14 (-1.92%)
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA

Transaction Represents Kamada's Entry into U.S. Plasma Collection Market and Advances the Company's Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company

KMDA : 6.14 (-1.92%)
Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel

Kamada Ltd. (Nasdaq: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that the Company has entered into agreements with two undisclosed international pharmaceutical companies...

KMDA : 6.14 (-1.92%)
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition

Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it has been selected as one of 10 winners of the Genesis Prize Foundation (GPF) Start-Up Nation Central...

KMDA : 6.14 (-1.92%)
Kamada Added to the NASDAQ Biotechnology Index

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI). The annual...

KMDA : 6.14 (-1.92%)
IBB : 156.93 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona,...

See More

Key Turning Points

3rd Resistance Point 6.57
2nd Resistance Point 6.42
1st Resistance Point 6.28
Last Price 6.14
1st Support Level 5.99
2nd Support Level 5.84
3rd Support Level 5.70

See More

52-Week High 13.33
Fibonacci 61.8% 9.92
Fibonacci 50% 8.86
Fibonacci 38.2% 7.81
Last Price 6.14
52-Week Low 4.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar